-
21
COVID-19 pandemic and vaccination rate in patients with psoriasis treated with biologics: A single center experience
Published 2024-01-01Subjects: “…biological therapy…”
Get full text
Article -
22
Is the Increase in Tumour Markers and Hashimoto’s Thyroiditis an Incidental Event During Dupilumab Treatment? A Case Report
Published 2025-02-01Subjects: Get full text
Article -
23
Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic Biomarkers
Published 2024-12-01Subjects: Get full text
Article -
24
An updated overview of Juvenile systemic sclerosis in a French cohort
Published 2025-02-01Subjects: Get full text
Article -
25
Safety of Dupilumab Therapy for Atopic Dermatitis during Pregnancy: A Systematic Review and Meta-analysis
Published 2025-02-01Subjects: Get full text
Article -
26
A year in review: new treatments and expanded indications in dermatology in 2024
Published 2025-12-01Subjects: Get full text
Article -
27
Biologics for eosinophilic oesophagitis: a systematic review and meta-analysis
Published 2025-12-01Subjects: Get full text
Article -
28
-
29
Romatolojide Kullanılan Biyolojik Tedaviler ve Hemşirelik Bakımı
Published 2022-04-01Subjects: Get full text
Article -
30
Features of Crohn's Disease Depending on the Age of Disease Onset
Published 2023-12-01Subjects: Get full text
Article -
31
The mitochondria as an emerging target of self-renewal in T-cell acute lymphoblastic leukemia
Published 2025-12-01“…Cancer Biology & Therapy…”
Get full text
Article -
32
Caspase 3-specific cleavage of ubiquitin-specific peptidase 48 enhances drug-induced apoptosis in AML
Published 2025-12-01“…Cancer Biology & Therapy…”
Get full text
Article -
33
Fractionated radiotherapy initiated at the early stage of bone metastasis is effective to prolong survival in mouse model
Published 2025-12-01“…Cancer Biology & Therapy…”
Get full text
Article -
34
Sigma1 inhibitor suppression of adaptive immune resistance mechanisms mediated by cancer cell derived extracellular vesicles
Published 2025-12-01“…Cancer Biology & Therapy…”
Get full text
Article -
35
Targeting the IKZF1/BCL-2 axis as a novel therapeutic strategy for treating acute T-cell lymphoblastic leukemia
Published 2025-12-01“…Cancer Biology & Therapy…”
Get full text
Article -
36
miR-301a-mediated crosstalk between the Hedgehog and HIPPO/YAP signaling pathways promotes pancreatic cancer
Published 2025-12-01“…Cancer Biology & Therapy…”
Get full text
Article -
37
A pan-cancer analysis of MARCH8: molecular characteristics, clinical relevance, and immuno-oncology features
Published 2025-12-01“…Cancer Biology & Therapy…”
Get full text
Article -
38
Granulocyte-Monocyte Apheresis in Steroid-Dependent, Azathioprine-Intolerant/Resistant Moderate Ulcerative Colitis: A Prospective Multicenter Study
Published 2017-01-01“…Apheresis might represent an alternative to biologic therapy or surgery in this specific subgroup of patients. …”
Get full text
Article -
39
Risk factors for Clostridioides difficile infection among patients diagnosed with inflammatory intestinal and rheumatological diseases in the biologic era
Published 2025-02-01“…The relationship between biologic therapy and CDI is controversial. We aimed to assess whether biologic therapy increases CDI risk among IBD patients, to identify factors associated with increased CDI risk, and to characterize CDI episodes in our population. …”
Get full text
Article -
40
Alternations of the gut microbiota and the Firmicutes/Bacteroidetes ratio after biologic treatment in inflammatory bowel disease
Published 2025-02-01“…The aim of our study was to analyze the intestinal microbiota composition in IBD across different severity levels and the impact of biologic therapy on microbiota modulation. Methods: In this study, 27 IBD patients were recruited, including 14 patients undergoing biologic therapy for moderate to severe disease activity and 13 controls with inactive disease. …”
Get full text
Article